Avalyn Pharma Inc. Common Stock (AVLN) Earnings Analysis
Avalyn Pharma Inc. Common Stock (AVLN) next reports earnings on 2026-09-02, consensus EPS -0.58 USD. Last quarter (2026-06-03) it missed with EPS -21.83 USD vs -5.97667 USD est (-265.3%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -14.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVLN next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.58 USD |
| Revenue estimate | n/a |
AVLN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-03 | -21.83 USD | -5.97667 USD | -265.3% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
AVLN valuation and analyst view
| Trailing P/E | -14.08 |
|---|---|
| Trailing EPS | -2.03779 USD |
| Price / book | -5.03 |
| Dividend yield | 0.00% |
| Market cap | 1.31B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Avalyn Pharma Inc. Common Stock (AVLN)'s next earnings date?
Avalyn Pharma Inc. Common Stock is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.58 USD.
Did AVLN beat earnings last quarter?
In its 2026-06-03 report, AVLN posted EPS of -21.83 USD versus a -5.97667 USD estimate — a miss of 265.3%.
What is AVLN's earnings track record?
Over the last 1 reported quarters with consensus data, AVLN beat estimates 0 times (0%).
What is AVLN's current P/E ratio and EPS?
AVLN trades at a trailing P/E of -14.08 on trailing EPS of -2.0377859041438464 USD.
What do analysts rate AVLN?
AVLN has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.